Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Peringkat dalam Saham #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Harga Saham
$1.51
Terakhir disinkronkan: 2024-08-26
Kapitalisasi Pasar
$1.12M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Agile Therapeutics, Inc. (AGRX)

Kategori

EPS untuk Agile Therapeutics, Inc. (AGRX)
EPS per June 2024 TTM: $-3.23
Menurut laporan keuangan terbaru dan harga saham Agile Therapeutics, Inc., EPS perusahaan saat ini (TTM) adalah $-3.23. Pada akhir 2022, perusahaan memiliki EPS sebesar $-58.79 penurunan dibandingkan dengan EPS tahun 2021 sebesar $-63.12K.
Riwayat EPS untuk Agile Therapeutics, Inc. dari 2012 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
2026 (TTM) $-3.23 -51.86%
2023 $-6.71 -88.59%
2022 $-58.79 -99.91%
2021 $-63.12K 4,786.76%
2020 $-1.29K 73.08%
2019 $-746.20 -35.27%
2018 $-1.15K -36.99%
2017 $-1.83K -10.01%
2016 $-2.03K -26.22%
2015 $-2.76K -2.35%
2014 $-2.82K -11.05%
2013 $-3.17K -38.43%
2012 $-5.15K 0.00%
EPS untuk perusahaan sejenis atau pesaing